Alan H. Bryce, MD, is a consultant and serves as chair of the Mayo Clinic Division of Hematology and Oncology, Department of Internal Medicine in Arizona. His primary focus is prostate and testicular cancers. Dr. Bryce’s research includes developing new treatments through clinical trials and a better understanding of cancer evolution through interrogation of the genetic mutations of individual cancer cells. He runs clinical trials of immunotherapy, genetically targeted therapies, hormone therapy, injectable radiotherapy and chemotherapy. Dr. Bryce is committed to health equity and patient-centered care. He believes that individualized medicine starts with tailoring all treatment to the patient’s goals and values.
U.S. News & World Report ranks Mayo Clinic #1 hospital in Arizona.